| Tumor suppressor LATS1 is a negative regulator of oncogene YAP Y Hao, A Chun, K Cheung, B Rashidi, X Yang Journal of Biological Chemistry 283 (9), 5496-5509, 2008 | 844 | 2008 |
| Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF D Lai, KC Ho, Y Hao, X Yang Cancer research 71 (7), 2728-2738, 2011 | 463 | 2011 |
| MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma J Chen, HE Feilotter, GC Paré, X Zhang, JGW Pemberton, C Garady, ... The American journal of pathology 176 (5), 2520-2529, 2010 | 290 | 2010 |
| The Hippo pathway component TAZ promotes immune evasion in human cancer through PD-L1 HJ Janse van Rensburg, T Azad, M Ling, Y Hao, B Snetsinger, P Khanal, ... Cancer research 78 (6), 1457-1470, 2018 | 242 | 2018 |
| LATS tumor suppressor: a new governor of cellular homeostasis S Visser, X Yang Cell cycle 9 (19), 3892-3903, 2010 | 239 | 2010 |
| LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1 X Yang, K Yu, Y Hao, D Li, R Stewart, KL Insogna, T Xu Nature cell biology 6 (7), 609-617, 2004 | 214 | 2004 |
| TAZ is a novel oncogene in non-small cell lung cancer Z Zhou, Y Hao, N Liu, L Raptis, MS Tsao, X Yang Oncogene 30 (18), 2181-2186, 2011 | 197 | 2011 |
| Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells X Yang, G Chernenko, Y Hao, Z Ding, MM Pater, A Pater, SC Tang Oncogene 17 (8), 981-989, 1998 | 184 | 1998 |
| Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation Y Nakao, X Yang, M Yokoyama, A Ferenczy, SC Tang, MM Pater, A Pater British journal of cancer 75 (10), 1410-1416, 1997 | 165 | 1997 |
| Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G2/M arrest or apoptosis X Yang, D Li, W Chen, T Xu Oncogene 20 (45), 6516-6523, 2001 | 150 | 2001 |
| Tumour suppressor genes in chemotherapeutic drug response D Lai, S Visser-Grieve, X Yang Bioscience reports 32 (4), 361-374, 2012 | 149 | 2012 |
| The Hippo pathway: immunity and cancer Z Taha, H J. Janse van Rensburg, X Yang Cancers 10 (4), 94, 2018 | 147 | 2018 |
| A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis T Azad, HJ Janse van Rensburg, ED Lightbody, B Neveu, A Champagne, ... Nature communications 9 (1), 1061, 2018 | 139 | 2018 |
| miR-193b regulates Mcl-1 in melanoma J Chen, X Zhang, C Lentz, M Abi-Daoud, GC Paré, X Yang, HE Feilotter, ... The American journal of pathology 179 (5), 2162-2168, 2011 | 137 | 2011 |
| The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death Z Ding, SC Tang, P Weerasinghe, X Yang, A Pater, A Liepins Biochemical pharmacology 63 (8), 1415-1421, 2002 | 136 | 2002 |
| Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability KC Ho, Z Zhou, YM She, A Chun, TD Cyr, X Yang Proceedings of the National Academy of Sciences 108 (12), 4870-4875, 2011 | 132 | 2011 |
| Response of photosynthetic capacity of tomato leaves to different LED light wavelength X Yang, H Xu, L Shao, T Li, Y Wang, R Wang Environmental and Experimental Botany 150, 161-171, 2018 | 112 | 2018 |
| The roles of the Hippo pathway in cancer metastasis HJJ van Rensburg, X Yang Cellular signalling 28 (11), 1761-1772, 2016 | 104 | 2016 |
| YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway Y Zhao, P Khanal, P Savage, YM She, TD Cyr, X Yang Cancer research 74 (16), 4493-4503, 2014 | 98 | 2014 |
| Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells Z Ding, X Yang, A Pater, SC Tang Biochemical and biophysical research communications 270 (2), 415-420, 2000 | 94 | 2000 |
